Epilepsy Monitoring Devices Market size was over USD 550.93 million in 2024 and is expected to cross USD 1.13 billion by the end of 2037, witnessing more than 5.9% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of epilepsy monitoring devices is estimated at USD 576.49 million.The growth of the market can be attributed to the growing number of people with epilepsy. Additionally, the aging of the population, across the globe is also expected to add to the market growth. The estimated prevalence of epilepsy beyond the age of 50 begins to rise and people under this age group are more prone to strokes, brain tumors, or Alzheimer's disease, all of which can lead to epilepsy. According to the World Health Organization (WHO), Epilepsy affects over 50 million individuals worldwide, making it one of the most prevalent neurological conditions worldwide.
In addition to these, factors that are believed to fuel the market growth of epilepsy monitoring devices include the rising usage of wearable devices. Consumers are increasingly using wearable electronics such as smartwatches, fitness trackers, hearing aids, medical devices, navigational aids, and smart glasses for remote work, health tracking, fitness activities, and other purposes. Furthermore, smartwatches for epilepsy are gaining popularity, as they recognize potential convulsive seizures and provide 24 hours of comfort and safety.
Growth Drivers
Increase in Brain Injuries– On account of the increasing road accidents, violence, or fall from bed, ladder, downstairs, washrooms, and other falls are the main causes of increasing brain injuries among people. The likelihood that someone may acquire epilepsy increases with the severity of the brain injury, as traumatic brain damage and other brain illnesses are closely related to epilepsy. As per estimates, there are more than 3 million traumatic brain injuries annually in the US.
Rising Geriatric Population – Elderly population is more prone to epilepsy and the rising number of elderly populations across the globe is estimated to drive market growth. The percentage of individuals over 60 in the world will nearly double from 12 to 22% between 2015 and 2050. As per data, today more than 8% of the world's population, is over the age of 65.
Increasing Innovations in Medical Devices – Government and other research centers have increased the investment in R&D activities to manage and treat illnesses, as well as to launch new medications and equipment, which are needed to prevent, diagnose, and monitor health issues. As per the World Health Organization (WHO), there are more than 7000 generic device groups and an estimated 2 million various types of medical devices available on the global market.
Growing Incidences of Brain Cancer & Brain Infections – It is expected that patients with brain Cancer & several other issues related to the brain, experience epilepsy more on a large scale, which is anticipated to drive the market growth. In 2022, more than 1,000 individuals were diagnosed with brain cancer globally.
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
5.9% |
|
Base Year Market Size (2024) |
USD 550.93 million |
|
Forecast Year Market Size (2037) |
USD 1.13 billion |
|
Regional Scope |
|
Technology (Vagus Nerve, Responsive Neuro, Deep Brain Stimulations, Accelerometry)
The global epilepsy monitoring devices market is segmented and analyzed for demand and supply by technology into vagus nerve, responsive neuro, deep brain stimulations, and accelerometry. Out of the four types, the deep brain stimulation segment is estimated to gain the largest market share over the projected time frame. The growth of the segment can be attributed to the increasing usage of deep brain stimulators to treat movement problems linked to Parkinson's disease (PD), essential tremors, epilepsy, dystonia, and other neurological illnesses. When medication alone is ineffective, deep brain stimulations may be used to treat persons with uncontrolled focal seizures. Further, it is also an alternative for those whose seizures cannot be controlled by other types of epilepsy surgery. According to statistics, deep brain stimulations have been performed on more than 100,000 individuals worldwide for a range of neurological and non-neurological problems.
End-user (Hospitals & Clinics, Home Care Settings)
The global epilepsy monitoring devices market is also segmented and analyzed for demand and supply by end-user in hospitals & clinics and home care settings. Amongst these three segments, the hospitals & clinics segment is expected to garner a significant share. Patients suffering from epilepsy diseases or disorders often visit hospitals for treatment, as the majority of electroencephalogram (EEG) devices and emergency medical services are used by hospitals and clinics. To perform the EEG technique a highly skilled professional known as a clinical neurophysiologist is needed, which is easily available on hospital premises. Further, the government has increased its spending on healthcare infrastructure to support the growth of hospitals and clinics. This, as a result, is anticipated to create numerous opportunities for the growth of the segment in the coming years.
Our in-depth analysis of the global market includes the following segments:
|
By Technology |
|
|
By Product |
|
|
By Epilepsy Detection & Prediction Devices |
|
|
By End-User |
|
Europe Market Forecast
The European epilepsy monitoring devices market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2037. The growth of the market can be attributed majorly to the increasing frequency of road accidents. For instance, high speed is the primary contributor to accidents in the region, followed by other factors including distracted driving. The biggest cause of mortality and severe injuries for teens and young adults is automobile accidents. A strong hit or jolt to the head during the accident can cause traumatic brain injury. If a person experiences seizures after suffering a traumatic brain injury, whether right away or even months or years later, there is a greater chance that they may develop epilepsy. For instance, epilepsy is the fourth most prevalent kind of brain disease in Europe. As of 2022, more than 2000 people died in traffic accidents in Germany.
North American Market Forecast
The North American epilepsy monitoring devices market, amongst the market in all the other regions, is projected to grow with the highest CAGR during the forecast period. The growth of the market can be attributed majorly to the growing adoption of wearable epilepsy monitoring devices. The technology is being adopted as a result of variables such as rising epilepsy prevalence, and rising epilepsy awareness in the region. Epilepsy affects over 3 million individuals in the United States, including both adults and children. Further, the growing cases of epilepsy in the region are usually the result of another neurological condition, such as a brain tumor or stroke. Additional factors may include developmental issues, past brain infections, fetal traumas, and genetic abnormalities.
Empatica Inc. has obtained Food and Drug Administration (FDA) approval for Embrace2, which employs AI (advanced machine learning) in a wristwatch. It uses Electrodermal Activity (EDA), a signal that stress researchers employ to measure physiological changes associated with sympathetic nervous system activity.
Magstim, Inc. developed ‘Horizon 3.0’, which has received clearance from the FDA (Food and Drug Administration) as a transcranial magnetic stimulation platform. It offers improved workflows with guided transcranial magnetic stimulation (TMS), and analytics for the therapeutic context.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?